Cover Image
市場調查報告書

美國的生檢設備市場預測

United States Biopsy Devices Market Outlook to 2023

出版商 GlobalData 商品編碼 311769
出版日期 內容資訊 英文 131 Pages
訂單完成後即時交付
價格
Back to Top
美國的生檢設備市場預測 United States Biopsy Devices Market Outlook to 2023
出版日期: 2017年03月01日 內容資訊: 英文 131 Pages
簡介

本報告依市場部門別提供您美國的生檢設備的銷售額及出貨量的實際成果與今後預測、平均價格的轉變。再彙整各市場類別的企業佔有率及流通佔有率資料、主要企業簡介、開發中產品、主要的財務交易情形等相關的最新資訊。

第1章 目錄

第2章 簡介

  • 關於本報告
  • 生檢設備市場分類
  • 本報告的市場範圍和定義

第3章 生檢設備的美國市場

  • 生檢設備的美國市場:收益的實際成果($m)
  • 生檢設備的美國市場:收益的預測($m)
    • 切片鉗的美國市場:各市場區隔收益($m)的實際成果
    • 活體組織切片槍的美國市場:各市場區隔收益($m)的實際成果
    • 生檢穿刺針的美國市場:各市場區隔收益($m)的實際成果
      • 粗針切片的美國市場:各子市場區隔收益($m)的實際成果
      • 抽吸生檢用細針(FNA)的美國市場:各子市場區隔收益($m)的實際成果
    • 鑽孔生檢的美國市場:各市場區隔收益($m)的實際成果
    • 切片鉗的美國市場:各市場區隔收益($m)的預測
    • 活體組織切片槍的美國市場:各市場區隔收益($m)的預測
    • 生檢穿刺針的美國市場:各市場區隔收益($m)的預測
      • 粗針切片的美國市場:各子市場區隔收益($m)的預測
      • 抽吸生檢用細針(FNA)的美國市場:各子市場區隔收益($m)的預測
    • 鑽孔生檢的美國市場:各市場區隔收益($m)的預測
  • 生檢設備的美國市場:出貨量的實際成果
  • 生檢設備的美國市場:出貨量的預測
    • 切片鉗的美國市場:各市場區隔出貨量的實際成果
    • 活體組織切片槍的美國市場:各市場區隔出貨量的實際成果
    • 生檢穿刺針的美國市場:各市場區隔出貨量的實際成果
      • 粗針切片的美國市場:各子市場區隔出貨量的實際成果
      • 抽吸生檢用細針(FNA)的美國市場:各子市場區隔出貨量的實際成果
    • 鑽孔生檢的美國市場:各市場區隔出貨量的實際成果
    • 切片鉗的美國市場:各市場區隔出貨量的預測
    • 活體組織切片槍的美國市場:各市場區隔出貨量的預測
    • 生檢穿刺針的美國市場:各市場區隔出貨量的預測
      • 粗針切片的美國市場:各子市場區隔出貨量的預測
      • 抽吸生檢用細針(FNA)的美國市場:各子市場區隔出貨量的預測
    • 鑽孔生檢的美國市場:各市場區隔出貨量的預測
  • 生檢設備的美國市場:平均銷售價格的轉變
  • 生檢設備的美國市場:以收益為準的流通佔有率($m)
  • 生檢設備的美國市場:以收益為準的企業佔有率($m)

第4章 美國的生檢設備市場上主要企業概要

  • C. R. Bard, Inc.
  • Hologic, Inc.
  • CareFusion Corporation
  • Devicor Medical Products, Inc.
  • Cook Group Incorporated
  • Argon Medical Devices Inc.
  • B. Braun Melsungen AG

第5章 生檢設備市場上開發中產品

第6章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's new report, "United States Biopsy Devices Market Outlook to 2023", provides key market data on the United States Biopsy Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Biopsy Guns & Needles, Biopsy Core Needles & Devices, Biopsy Fine Aspiration Needles & Devices, Biopsy Disposable Vacuum-Assisted Needle Devices, Biopsy Forceps and Biopsy Punches.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Biopsy Devices market segments - Biopsy Guns & Needles, Biopsy Core Needles & Devices, Biopsy Fine Aspiration Needles & Devices, Biopsy Disposable Vacuum-Assisted Needle Devices, Biopsy Forceps and Biopsy Punches.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Biopsy Devices market.
  • Key players covered include C. R. Bard Inc, Becton Dickinson and Co, Cook Group Inc and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 5

2 Introduction 7

  • 2.1 What Is This Report About? 7
  • 2.2 Biopsy Devices Market Segmentation 7
  • 2.3 Definitions of Markets Covered in the Report 8

3 Biopsy Devices Market, United States 10

  • 3.1 Biopsy Devices Market, United States, Revenue ($m), 2009-2016 10
  • 3.2 Biopsy Devices Market, United States, Revenue ($m), 2016-2023 12
    • 3.2.1 Biopsy Core Needles & Devices Market, United States, Revenue ($m), by Segment, 2009-2016 14
    • 3.2.2 Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), by Segment, 2009-2016 16
    • 3.2.3 Biopsy Forceps Market, United States, Revenue ($m), by Segment, 2009-2016 18
    • 3.2.4 Biopsy Guns & Needles Market, United States, Revenue ($m), by Segment, 2009-2016 20
    • 3.2.5 Biopsy Punches Market, United States, Revenue ($m), by Segment, 2009-2016 22
    • 3.2.6 Biopsy Core Needles & Devices Market, United States, Revenue ($m), by Segment, 2016-2023 24
    • 3.2.7 Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), by Segment, 2016-2023 26
    • 3.2.8 Biopsy Forceps Market, United States, Revenue ($m), by Segment, 2016-2023 28
    • 3.2.9 Biopsy Guns & Needles Market, United States, Revenue ($m), by Segment, 2016-2023 30
    • 3.2.10 Biopsy Punches Market, United States, Revenue ($m), by Segment, 2016-2023 32
  • 3.3 Biopsy Devices Market, United States, Volume (Units), 2009-2016 34
  • 3.4 Biopsy Devices Market, United States, Volume (Units), 2016-2023 36
    • 3.4.1 Biopsy Core Needles & Devices Market, United States, Volume (Units), by Segment, 2009-2016 38
    • 3.4.2 Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), by Segment, 2009-2016 40
    • 3.4.3 Biopsy Forceps Market, United States, Volume (Units), by Segment, 2009-2016 42
    • 3.4.4 Biopsy Guns & Needles Market, United States, Volume (Units), by Segment, 2009-2016 44
    • 3.4.5 Biopsy Punches Market, United States, Volume (Units), by Segment, 2009-2016 46
    • 3.4.6 Biopsy Core Needles & Devices Market, United States, Volume (Units), by Segment, 2016-2023 48
    • 3.4.7 Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), by Segment, 2016-2023 50
    • 3.4.8 Biopsy Forceps Market, United States, Volume (Units), by Segment, 2016-2023 52
    • 3.4.9 Biopsy Guns & Needles Market, United States, Volume (Units), by Segment, 2016-2023 54
    • 3.4.10 Biopsy Punches Market, United States, Volume (Units), by Segment, 2016-2023 56
  • 3.5 Biopsy Devices Market, United States, Average Price ($), 2009-2023 58
  • 3.6 Biopsy Devices Market, United States, Distribution Share by Revenue ($m), 2015-2016 60
  • 3.7 Biopsy Devices Market, United States, Company Share by Revenue ($m), 2016 61

4 Overview of Key Companies in United States, Biopsy Devices Market 63

  • 4.1 C. R. Bard Inc 63
    • 4.1.1 Company Overview 63
  • 4.2 Becton Dickinson and Co 63
    • 4.2.1 Company Overview 63
  • 4.3 Cook Group Inc 63
    • 4.3.1 Company Overview 63
  • 4.4 Argon Medical Devices Inc. 63
    • 4.4.1 Company Overview 63
  • 4.5 Devicor Medical Products Inc 64
    • 4.5.1 Company Overview 64

5 Biopsy Devices Market Pipeline Products 65

6 Financial Deals Landscape 67

  • 6.1 Acquisition 67
    • 6.1.1 Teleflex Acquires Vascular Solutions for up to USD1 Billion 67
    • 6.1.2 Boston Scientific Acquires EndoChoice for USD210 Million in Tender Offer 69
    • 6.1.3 Avant Diagnostics Acquires Theranostics Health 71
  • 6.2 Debt Offerings 72
    • 6.2.1 C. R. Bard Prices Public Offering of 3% Notes Due 2026 for USD500 Million 72
  • 6.3 Partnerships 73
    • 6.3.1 Exosome Diagnostics Enters into Agreement with Amgen 73
    • 6.3.2 Devicor Medical Products Enters into Distribution Agreement with Endomagnetics 74
    • 6.3.3 Scion Medical Technologies Enters into Distribution Agreement with Mermaid Medical 75
    • 6.3.4 Fluxion Bioscience Forms Partnership with University of Texas Health Science Center 76
  • 6.4 Venture Financing 77
    • 6.4.1 VIDA Diagnostics Raises USD5.1 Million in Series B Round of Financing 77
    • 6.4.2 Veran Medical Technologies Raises USD31 Million in Venture Financing 79

7 Recent Developments 81

  • 7.1 Corporate Communications 81
    • 7.1.1 Jan 30, 2017: Dr. Yaron Pereg Appointed as New Chief Development Officer 81
    • 7.1.2 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 81
    • 7.1.3 Jan 03, 2017: Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer 81
    • 7.1.4 Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 82
    • 7.1.5 Oct 26, 2016: Elisha W. Finney Announces Plan to Retire as CFO of Varian Medical Systems 82
    • 7.1.6 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 83
    • 7.1.7 Sep 26, 2016: Jon Giacomin of Cardinal Health Elected Chairman of HDA Board of Directors 83
    • 7.1.8 Sep 08, 2016: iCAD Announces Management Transition 84
    • 7.1.9 Aug 22, 2016: Judy Bruner Appointed to Board of Directors of Varian Medical Systems; Venkatraman Thyagarajan Retires from Varian Board 84
    • 7.1.10 Jul 26, 2016: Merit Medical Announces Appointment of New Director 85
    • 7.1.11 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 85
    • 7.1.12 Jun 30, 2016: Cardinal Health Appoints Pamela O. Kimmet Chief Human Resources Officer 85
    • 7.1.13 Mar 07, 2016: Varian Medical Systems Announces Particle Therapy Scientific Advisory Board 86
    • 7.1.14 Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors 87
  • 7.2 Financial Announcements 87
    • 7.2.1 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 87
    • 7.2.2 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 88
    • 7.2.3 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 89
    • 7.2.4 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 90
    • 7.2.5 Jan 26, 2017: Bard Announces Fourth Quarter Results 91
    • 7.2.6 Jan 25, 2017: Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2017 92
    • 7.2.7 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 93
    • 7.2.8 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 94
    • 7.2.9 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 95
    • 7.2.10 Nov 02, 2016: iCAD Reports Third Quarter 2016 Financial Results 96
    • 7.2.11 Oct 31, 2016: Cardinal Health Reports First-quarter Results for Fiscal Year 2017 98
    • 7.2.12 Oct 27, 2016: Stryker reports third quarter 2016 results 99
    • 7.2.13 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 100
    • 7.2.14 Oct 26, 2016: Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2016 101
    • 7.2.15 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 102
    • 7.2.16 Oct 25, 2016: Bard Announces Third Quarter Results 103
    • 7.2.17 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results 103
    • 7.2.18 Aug 03, 2016: EndoChoice Announces Second Quarter 2016 Financial Results 105
    • 7.2.19 Aug 02, 2016: Cardinal Health Reports Q4 And Fiscal 2016 Results, Provides Fiscal 2017 Outlook 106
    • 7.2.20 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 108
    • 7.2.21 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 109
    • 7.2.22 Jul 27, 2016: iCAD Reports Second Quarter 2016 Financial Results 110
    • 7.2.23 Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 111
    • 7.2.24 Jul 27, 2016: Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2016 112
    • 7.2.25 Jul 26, 2016: Bard Announces Second Quarter Results 113
    • 7.2.26 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results 114
    • 7.2.27 Jul 21, 2016: Stryker reports second quarter 2016 results 116
    • 7.2.28 Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016 117
    • 7.2.29 Apr 27, 2016: Varian Medical Systems Reports Results For Second Quarter Of Fiscal Year 2016 118
    • 7.2.30 Apr 27, 2016: Bard Announces First Quarter Results 119
  • 7.3 Legal And Regulatory 119
    • 7.3.1 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia 119
    • 7.3.2 Dec 23, 2016: Cardinal Health Announces Civil Settlement with DOJ 119
  • 7.4 Other Significant Developments 120
    • 7.4.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 120
    • 7.4.2 Jul 21, 2016: Varian Medical Systems Announces Company Name For Imaging Components Business 121
    • 7.4.3 Jul 19, 2016: Braeburn Pharmaceuticals to Conduct First Series of Probuphine (buprenorphine) Implant Trainings on July 22, 23 and 24 for Qualified Healthcare Providers in US 121
    • 7.4.4 Jun 28, 2016: Allied Minds Strengthens Commercialization Partnership with The MITRE 122
    • 7.4.5 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 123
    • 7.4.6 May 19, 2016: Largest Hospital Chain in India Selects Varian Advanced Radiotherapy Equipment 123
  • 7.5 Strategy And Business Planning 124
    • 7.5.1 Mar 03, 2016: Varian Medical Systems Breaks Ground On New Brazil Facility 124

8 Appendix 125

  • 8.1 Research Methodology 126
    • 8.1.1 Coverage 126
    • 8.1.2 Secondary Research 126
    • 8.1.3 Primary Research 127
    • 5.1.4 Market Modeling and Forecasting 128
    • 8.1.5 Company Share Analysis 129
    • 8.1.6 Distribution Share Analysis 130
    • 8.1.7 Benchmarking 130
  • 8.2 GlobalData Consulting 130
  • 8.3 Contact Us 131
  • 8.4 Disclaimer 131

List of Tables

  • Table 1: Biopsy Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 11
  • Table 2: Biopsy Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 13
  • Table 3: Biopsy Core Needles & Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 15
  • Table 4: Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 17
  • Table 5: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 19
  • Table 6: Biopsy Guns & Needles Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 21
  • Table 7: Biopsy Punches Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 23
  • Table 8: Biopsy Core Needles & Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 25
  • Table 9: Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 27
  • Table 10: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 29
  • Table 11: Biopsy Guns & Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 31
  • Table 12: Biopsy Punches Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 33
  • Table 13: Biopsy Devices Market, United States, Volume (Units), Historic, 2009-2016 35
  • Table 14: Biopsy Devices Market, United States, Volume (Units), Forecast, 2016-2023 37
  • Table 15: Biopsy Core Needles & Devices Market, United States, Volume (Units), Historic, 2009-2016 39
  • Table 16: Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), Historic, 2009-2016 41
  • Table 17: Biopsy Forceps Market, United States, Volume (Units), Historic, 2009-2016 43
  • Table 18: Biopsy Guns & Needles Market, United States, Volume (Units), Historic, 2009-2016 45
  • Table 19: Biopsy Punches Market, United States, Volume (Units), Historic, 2009-2016 47
  • Table 20: Biopsy Core Needles & Devices Market, United States, Volume (Units), Forecast, 2016-2023 49
  • Table 21: Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), Forecast, 2016-2023 51
  • Table 22: Biopsy Forceps Market, United States, Volume (Units), Forecast, 2016-2023 53
  • Table 23: Biopsy Guns & Needles Market, United States, Volume (Units), Forecast, 2016-2023 55
  • Table 24: Biopsy Punches Market, United States, Volume (Units), Forecast, 2016-2023 57
  • Table 25: Biopsy Devices Market, United States, Average Price ($) Historic, 2009-2023 58
  • Table 26: Biopsy Devices Market, United States, Average Price ($), Forecast, 2016-2023 59
  • Table 27: Biopsy Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 60
  • Table 28: Biopsy Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 62
  • Table 29: Biopsy Devices Market Pipeline Products 65
  • Table 30: Teleflex Acquires Vascular Solutions for up to USD1 Billion 67
  • Table 31: Boston Scientific Acquires EndoChoice for USD210 Million in Tender Offer 69
  • Table 32: Avant Diagnostics Acquires Theranostics Health 71
  • Table 33: C. R. Bard Prices Public Offering of 3% Notes Due 2026 for USD500 Million 72
  • Table 34: Exosome Diagnostics Enters into Agreement with Amgen 73
  • Table 35: Devicor Medical Products Enters into Distribution Agreement with Endomagnetics 74
  • Table 36: Scion Medical Technologies Enters into Distribution Agreement with Mermaid Medical 75
  • Table 37: Fluxion Bioscience Forms Partnership with University of Texas Health Science Center 76
  • Table 38: VIDA Diagnostics Raises USD5.1 Million in Series B Round of Financing 77
  • Table 39: Veran Medical Technologies Raises USD31 Million in Venture Financing 79
  • Table 40: Total Number of Primary Research Participants, General Surgery Market, by Country 128

List of Figures

  • Figure 1: Biopsy Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 10
  • Figure 2: Biopsy Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 12
  • Figure 3: Biopsy Core Needles & Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 14
  • Figure 4: Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 16
  • Figure 5: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 18
  • Figure 6: Biopsy Guns & Needles Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 20
  • Figure 7: Biopsy Punches Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 22
  • Figure 8: Biopsy Core Needles & Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 24
  • Figure 9: Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 26
  • Figure 10: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 28
  • Figure 11: Biopsy Guns & Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 30
  • Figure 12: Biopsy Punches Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 32
  • Figure 13: Biopsy Devices Market, United States, Volume (Units), Historic, 2009-2016 34
  • Figure 14: Biopsy Devices Market, United States, Volume (Units), Forecast, 2016-2023 36
  • Figure 15: Biopsy Core Needles & Devices Market, United States, Volume (Units), Historic, 2009-2016 38
  • Figure 16: Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), Historic, 2009-2016 40
  • Figure 17: Biopsy Forceps Market, United States, Volume (Units), Historic, 2009-2016 42
  • Figure 18: Biopsy Guns & Needles Market, United States, Volume (Units), Historic, 2009-2016 44
  • Figure 19: Biopsy Punches Market, United States, Volume (Units), Historic, 2009-2016 46
  • Figure 20: Biopsy Core Needles & Devices Market, United States, Volume (Units), Forecast, 2016-2023 48
  • Figure 21: Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), Forecast, 2016-2023 50
  • Figure 22: Biopsy Forceps Market, United States, Volume (Units), Forecast, 2016-2023 52
  • Figure 23: Biopsy Guns & Needles Market, United States, Volume (Units), Forecast, 2016-2023 54
  • Figure 24: Biopsy Punches Market, United States, Volume (Units), Forecast, 2016-2023 56
  • Figure 25: Biopsy Devices Market, United States, Company Share (%) 2016 61
Back to Top